Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Defesche

Showing results (151-160 of 178) with videos related to

Pageof 18
Sort By:
Diabetes Care|April 29, 2006
The effects of the Pro12Ala polymorphism of the peroxisome proliferator-activated receptor-gamma2 gene on glucose/insulin metabolism interact with prenatal exposure to famineSusanne R de Rooij, Rebecca C Painter, David I W Phillips, et al.
The Lancet. Diabetes & Endocrinology|January 30, 2026
Efficacy and safety of inclisiran in adolescents with heterozygous familial hypercholesterolaemia (ORION-16): a two-part, randomised, multicentre clinical trialAlbert Wiegman, Amy L Peterson, Eric Bruckert, et al.
Circulation|October 30, 2015
The Agenda for Familial Hypercholesterolemia: A Scientific Statement From the American Heart AssociationSamuel S Gidding, Mary Ann Champagne, Sarah D de Ferranti, et al.
European Journal of Human Genetics : EJHG|September 13, 2012
Low-density lipoprotein receptor mutations generate synthetic genome-wide associationsDaniëlla M Oosterveer, Jorie Versmissen, Joep C Defesche, et al.
European Heart Journal|July 5, 2008
Replication study of 10 genetic polymorphisms associated with coronary heart disease in a specific high-risk population with familial hypercholesterolemiaJeroen B van der Net, Daniëlla M Oosterveer, Jorie Versmissen, et al.
Atherosclerosis|September 9, 2008
Arachidonate 5-lipoxygenase-activating protein (ALOX5AP) gene and coronary heart disease risk in familial hypercholesterolemiaJeroen B van der Net, Jorie Versmissen, Daniëlla M Oosterveer, et al.
Circulation. Genomic and Precision Medicine|September 7, 2023
Low-Cost High-Throughput Genotyping for Diagnosing Familial HypercholesterolemiaShirin Ibrahim, Jeroen van Rooij, Annemieke J M H Verkerk, et al.
Atherosclerosis|February 15, 2011
Proteinuria in early childhood due to familial LCAT deficiency caused by loss of a disulfide bond in lecithin:cholesterol acyl transferaseA G Holleboom, J A Kuivenhoven, C C van Olden, et al.
Circulation. Cardiovascular Genetics|October 20, 2011
Apolipoprotein isoform E4 does not increase coronary heart disease risk in carriers of low-density lipoprotein receptor mutationsJorie Versmissen, Daniëlla M Oosterveer, Menno Hoekstra, et al.
Journal of Internal Medicine|January 14, 2012
Mutations in LPL, APOC2, APOA5, GPIHBP1 and LMF1 in patients with severe hypertriglyceridaemiaR P Surendran, M E Visser, S Heemelaar, et al.
Pageof 18

Showing results (151-160 of 178) with videos related to

Sort By:
Pageof 18
Diabetes Care|April 29, 2006
The effects of the Pro12Ala polymorphism of the peroxisome proliferator-activated receptor-gamma2 gene on glucose/insulin metabolism interact with prenatal exposure to famineSusanne R de Rooij, Rebecca C Painter, David I W Phillips, et al.
The Lancet. Diabetes & Endocrinology|January 30, 2026
Efficacy and safety of inclisiran in adolescents with heterozygous familial hypercholesterolaemia (ORION-16): a two-part, randomised, multicentre clinical trialAlbert Wiegman, Amy L Peterson, Eric Bruckert, et al.
Circulation|October 30, 2015
The Agenda for Familial Hypercholesterolemia: A Scientific Statement From the American Heart AssociationSamuel S Gidding, Mary Ann Champagne, Sarah D de Ferranti, et al.
European Journal of Human Genetics : EJHG|September 13, 2012
Low-density lipoprotein receptor mutations generate synthetic genome-wide associationsDaniëlla M Oosterveer, Jorie Versmissen, Joep C Defesche, et al.
European Heart Journal|July 5, 2008
Replication study of 10 genetic polymorphisms associated with coronary heart disease in a specific high-risk population with familial hypercholesterolemiaJeroen B van der Net, Daniëlla M Oosterveer, Jorie Versmissen, et al.
Atherosclerosis|September 9, 2008
Arachidonate 5-lipoxygenase-activating protein (ALOX5AP) gene and coronary heart disease risk in familial hypercholesterolemiaJeroen B van der Net, Jorie Versmissen, Daniëlla M Oosterveer, et al.
Circulation. Genomic and Precision Medicine|September 7, 2023
Low-Cost High-Throughput Genotyping for Diagnosing Familial HypercholesterolemiaShirin Ibrahim, Jeroen van Rooij, Annemieke J M H Verkerk, et al.
Atherosclerosis|February 15, 2011
Proteinuria in early childhood due to familial LCAT deficiency caused by loss of a disulfide bond in lecithin:cholesterol acyl transferaseA G Holleboom, J A Kuivenhoven, C C van Olden, et al.
Circulation. Cardiovascular Genetics|October 20, 2011
Apolipoprotein isoform E4 does not increase coronary heart disease risk in carriers of low-density lipoprotein receptor mutationsJorie Versmissen, Daniëlla M Oosterveer, Menno Hoekstra, et al.
Journal of Internal Medicine|January 14, 2012
Mutations in LPL, APOC2, APOA5, GPIHBP1 and LMF1 in patients with severe hypertriglyceridaemiaR P Surendran, M E Visser, S Heemelaar, et al.
Pageof 18